HCA

SEC source: 0000950170-24-127316 · ownership.xml · nonDerivative · entry 3

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,702.0749

F1 · balance_after: Includes 2,367.0749 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-24-127310 · ownership.xml · nonDerivative · entry 3

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,843

SEC source: 0000950170-24-128122 · ownership.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,454

SEC source: 0000950170-24-128118 · ownership.xml · derivative · entry 11

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,600 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 10

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,278

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 9

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 8

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 18,000

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 7

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,580

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 6

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By JMF Trust (Spouse and Robert Nagel, Co-Trustees)

Disclosed balance after: 66,515

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 5

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,580

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 4

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By JMF Trust (Spouse and Robert Nagel, Co-Trustees)

Disclosed balance after: 64,560

F1 · kind: Pursuant to a power of substitution, on November 14, 2024, the Reporting Person transferred 9,502 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $352.74 (the average of the high and low prices of shares of common stock of the Issuer on November 14, 2024). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 3

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,535

F1 · kind: Pursuant to a power of substitution, on November 14, 2024, the Reporting Person transferred 9,502 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $352.74 (the average of the high and low prices of shares of common stock of the Issuer on November 14, 2024). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000950170-24-127316 · ownership.xml · derivative · entry 4

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016

SEC source: 0000950170-24-127316 · ownership.xml · nonDerivative · entry 2

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,599.0749

F1 · balance_after: Includes 2,367.0749 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-24-127316 · ownership.xml · nonDerivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,702.0749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,367.0749 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-24-127310 · ownership.xml · derivative · entry 6

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

SEC source: 0000950170-24-127310 · ownership.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,743

SEC source: 0000950170-24-127310 · ownership.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-126550 · ownership.xml · derivative · entry 3

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,570

Underlying: Common Stock · 4,710 shares

Expires 2031-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.

SEC source: 0000950170-24-126550 · ownership.xml · nonDerivative · entry 2

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,928

SEC source: 0000950170-24-126550 · ownership.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000891836-24-000048 · primary_doc.xml · nonDerivative · entry 6

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly by Trusts

Disclosed balance after: 9,668,536.3632

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F5 · ownership.nature: The Reporting Person is trustee of nine trusts for the benefit of her children, and the Reporting Person's spouse is trustee of three trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 147,261 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 9,521,275.363238 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F9 · ownership.nature: Pursuant to a power of substitution, on October 30, 2024, the Reporting Person transferred 138,000 jointly owned units of Hercules to The Patricia Frist Elcan 2011 Family Trust, 638,573.9641 jointly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee and 244,626.0359 directly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee. (continued in footnote 10)

F10 · ownership.nature: (continued from footnote 9) Each of these transfers was made at a price per unit of Hercules equal to $361.55 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on October 30, 2024), which price was paid by transfer of a diversified basket of marketable securities and $13,726.20 in cash (in the case of The Patricia Frist Elcan 2011 Family Trust) and a diversified basket of marketable securities, mutual fund shares and $18,766,307.56 in cash (in the case of the three trusts). In each case, these transfers did not change the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000891836-24-000048 · primary_doc.xml · nonDerivative · entry 5

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly by Trusts

Disclosed balance after: 9,029,962.3991

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F5 · ownership.nature: The Reporting Person is trustee of nine trusts for the benefit of her children, and the Reporting Person's spouse is trustee of three trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 147,261 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 9,521,275.363238 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F9 · ownership.nature: Pursuant to a power of substitution, on October 30, 2024, the Reporting Person transferred 138,000 jointly owned units of Hercules to The Patricia Frist Elcan 2011 Family Trust, 638,573.9641 jointly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee and 244,626.0359 directly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee. (continued in footnote 10)

F10 · ownership.nature: (continued from footnote 9) Each of these transfers was made at a price per unit of Hercules equal to $361.55 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on October 30, 2024), which price was paid by transfer of a diversified basket of marketable securities and $13,726.20 in cash (in the case of The Patricia Frist Elcan 2011 Family Trust) and a diversified basket of marketable securities, mutual fund shares and $18,766,307.56 in cash (in the case of the three trusts). In each case, these transfers did not change the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000891836-24-000048 · primary_doc.xml · nonDerivative · entry 4

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Frist Elcan 2011 Family Trust

Disclosed balance after: 264,216.917

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F4 · ownership.nature: The Reporting Person's spouse is the trustee of The Patricia Frist Elcan 2011 Family Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the 264,216.916981 units of Hercules held by such trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F9 · ownership.nature: Pursuant to a power of substitution, on October 30, 2024, the Reporting Person transferred 138,000 jointly owned units of Hercules to The Patricia Frist Elcan 2011 Family Trust, 638,573.9641 jointly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee and 244,626.0359 directly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee. (continued in footnote 10)

F10 · ownership.nature: (continued from footnote 9) Each of these transfers was made at a price per unit of Hercules equal to $361.55 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on October 30, 2024), which price was paid by transfer of a diversified basket of marketable securities and $13,726.20 in cash (in the case of The Patricia Frist Elcan 2011 Family Trust) and a diversified basket of marketable securities, mutual fund shares and $18,766,307.56 in cash (in the case of the three trusts). In each case, these transfers did not change the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000891836-24-000048 · primary_doc.xml · nonDerivative · entry 3

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 0

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F3 · ownership.nature: The Reporting Person jointly owned with her spouse 776,573.9641 units of Hercules and therefore may have been deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of her ownership in Hercules.

F9 · ownership.nature: Pursuant to a power of substitution, on October 30, 2024, the Reporting Person transferred 138,000 jointly owned units of Hercules to The Patricia Frist Elcan 2011 Family Trust, 638,573.9641 jointly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee and 244,626.0359 directly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee. (continued in footnote 10)

F10 · ownership.nature: (continued from footnote 9) Each of these transfers was made at a price per unit of Hercules equal to $361.55 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on October 30, 2024), which price was paid by transfer of a diversified basket of marketable securities and $13,726.20 in cash (in the case of The Patricia Frist Elcan 2011 Family Trust) and a diversified basket of marketable securities, mutual fund shares and $18,766,307.56 in cash (in the case of the three trusts). In each case, these transfers did not change the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000891836-24-000048 · primary_doc.xml · nonDerivative · entry 2

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 638,573.9641

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F3 · ownership.nature: The Reporting Person jointly owned with her spouse 776,573.9641 units of Hercules and therefore may have been deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of her ownership in Hercules.

F9 · ownership.nature: Pursuant to a power of substitution, on October 30, 2024, the Reporting Person transferred 138,000 jointly owned units of Hercules to The Patricia Frist Elcan 2011 Family Trust, 638,573.9641 jointly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee and 244,626.0359 directly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee. (continued in footnote 10)

F10 · ownership.nature: (continued from footnote 9) Each of these transfers was made at a price per unit of Hercules equal to $361.55 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on October 30, 2024), which price was paid by transfer of a diversified basket of marketable securities and $13,726.20 in cash (in the case of The Patricia Frist Elcan 2011 Family Trust) and a diversified basket of marketable securities, mutual fund shares and $18,766,307.56 in cash (in the case of the three trusts). In each case, these transfers did not change the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000891836-24-000048 · primary_doc.xml · nonDerivative · entry 1

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 404,512.0997

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F2 · ownership.nature: The Reporting Person directly owns 404,512.099655 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of her ownership in Hercules.

F9 · ownership.nature: Pursuant to a power of substitution, on October 30, 2024, the Reporting Person transferred 138,000 jointly owned units of Hercules to The Patricia Frist Elcan 2011 Family Trust, 638,573.9641 jointly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee and 244,626.0359 directly owned units of Hercules to three trusts for the benefit of her children of which the Reporting Person's spouse is trustee. (continued in footnote 10)

F10 · ownership.nature: (continued from footnote 9) Each of these transfers was made at a price per unit of Hercules equal to $361.55 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on October 30, 2024), which price was paid by transfer of a diversified basket of marketable securities and $13,726.20 in cash (in the case of The Patricia Frist Elcan 2011 Family Trust) and a diversified basket of marketable securities, mutual fund shares and $18,766,307.56 in cash (in the case of the three trusts). In each case, these transfers did not change the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0000950170-24-106008 · ownership.xml · nonDerivative · entry 3

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,678.2085

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024.

F2 · balance_after: Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-24-106008 · ownership.xml · derivative · entry 4

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,080 shares

Expires 2030-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024.

F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.

SEC source: 0000950170-24-106008 · ownership.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,036.2085

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024.

F2 · balance_after: Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-24-106008 · ownership.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,758.2085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024.

F2 · balance_after: Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans.

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 8

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By HD Trust

Disclosed balance after: 14,979

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 7

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

SEC source: 0000950170-24-095535 · ownership.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By MAM 2020 Trust

Disclosed balance after: 43,227

SEC source: 0000950170-24-095535 · ownership.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 6

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 Trust

Disclosed balance after: 3,012

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 5

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,200

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 4

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 GST Trust

Disclosed balance after: 16,731

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 3

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,212

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 7,115

SEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,296

SEC source: 0000950170-24-093147 · ownership.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 Trust

Disclosed balance after: 18,526

SEC source: 0000950170-24-093147 · ownership.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0000950170-24-088748 · ownership.xml · nonDerivative · entry 4

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,454

SEC source: 0000950170-24-090123 · ownership.xml · derivative · entry 3

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,440

Underlying: Common Stock · 7,500 shares

Expires 2026-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on July 29, 2017.

SEC source: 0000950170-24-090123 · ownership.xml · nonDerivative · entry 2

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,008.4141

SEC source: 0000950170-24-090123 · ownership.xml · nonDerivative · entry 1

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,927.4141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-087383 · ownership.xml · nonDerivative · entry 3

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,449

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.05 to $360.205, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-088748 · ownership.xml · derivative · entry 5

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,280 shares

Expires 2030-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.

SEC source: 0000950170-24-088748 · ownership.xml · nonDerivative · entry 3

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,441